Quality of Life in Emicizumab-treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study – An Assessment of Baseline PROMIS®-29 Scores

Author(s):
Tyler W Buckner, Nabil Daoud, Lucy Lee, Jonathan Schwartz, Karina Raimundo, Michael Recht
Publication:
Blood
Date:
November 28, 2023
Topics:
hemophilia A, emicizumab, ATHN 7

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.